Rodrigue James R, Hanto Douglas W, Curry Michael P
Beth Israel Deaconess Medical Center and the Harvard Medical School, Boston, Massachusetts.
Prog Transplant. 2013 Dec;23(4):310-8. doi: 10.7182/pit2013604.
Alcohol relapse after liver transplant heightens concern about recurrent disease, nonadherence to the immunosuppression regimen, and death.
To develop a scoring system to stratify risk of alcohol relapse after liver transplant.
Retrospective medical record review.
All adult liver transplants performed from May 2002 to February 2011 at a single center in the United States.
The incidence of return to any alcohol consumption after liver transplant.
Thirty-four percent (40/118) of patients with a history of alcohol abuse/dependency relapsed to use of any alcohol after liver transplant. Nine of 25 hypothesized risk factors were predictive of alcohol relapse after liver transplant: absence of hepatocellular carcinoma, tobacco dependence, continued alcohol use after liver disease diagnosis, low motivation for alcohol treatment, poor stress management skills, no rehabilitation relationship, limited social support, lack of nonmedical behavioral consequences, and continued engagement in social activities with alcohol present. Each independent predictor was assigned an Alcohol Relapse Risk Assessment (ARRA) risk value of 1 point, and patients were classified into 1 of 4 groups by ARRA score: ARRA I = 0, ARRA II = 1 to 3, ARRA III = 4 to 6, and ARRA IV = 7 to 9. Patients in the 2 higher ARRA classifications had significantly higher rates of alcohol relapse and were more likely to return to pretransplant levels of drinking.
Alcohol relapse rates are moderately high after liver transplant. The ARRA is a valid and practical tool for identifying pretransplant patients with alcohol abuse or dependency at elevated risk of any alcohol use after liver transplant.
肝移植后酒精复饮增加了对疾病复发、不遵守免疫抑制方案以及死亡的担忧。
开发一种评分系统以对肝移植后酒精复饮风险进行分层。
回顾性病历审查。
2002年5月至2011年2月在美国一个中心进行的所有成人肝移植手术。
肝移植后恢复饮酒的发生率。
有酒精滥用/依赖史的患者中,34%(40/118)在肝移植后复饮。25个假设的风险因素中有9个可预测肝移植后酒精复饮:无肝细胞癌、烟草依赖、肝病诊断后持续饮酒、酒精治疗动机低、压力管理技能差、无康复关系、社会支持有限、缺乏非医疗行为后果以及在有酒精的社交活动中持续参与。每个独立预测因素被赋予1分的酒精复饮风险评估(ARRA)风险值,患者根据ARRA评分分为4组中的1组:ARRA I = 0,ARRA II = 1至3,ARRA III = 4至6,ARRA IV = 7至9。ARRA分类较高的两组患者酒精复饮率显著更高,且更有可能恢复到移植前的饮酒水平。
肝移植后酒精复饮率中等偏高。ARRA是一种有效且实用的工具,用于识别肝移植后有饮酒风险升高的酒精滥用或依赖的移植前患者。